New Brain Research Offers Hope for Targeted PTSD Therapies
Table of Contents
A groundbreaking study published in Cell Reports reveals new insights into the neural mechanisms underlying fear, possibly paving the way for more effective treatments for post-traumatic stress disorder (PTSD).
Northwestern Medicine investigators have identified key differences in how distinct groups of brain cells respond to fear and its extinction, offering a more nuanced understanding of the complex neurological processes at play. The research, led by Sachin Patel, MD, phd, chair and the Lizzie Gilman Professor of Psychiatry and Behavioral Sciences, focuses on GABAergic interneurons (INs) – specialized inhibitory neurons in the amygdala crucial for learning and regulating brain activity.
Decoding the Brain’s Fear Response
“This is also important from a clinical viewpoint because it’s the basis of things like exposure therapy where patients are exposed to traumatic cues over and over again in a safe place with the hope that those conditioned responses will decrease over time,” a senior researcher stated. “Understanding how these GABAergic neurons are playing a role in this process in a coordinated way has never really been examined.”
Mouse Models Reveal Key Differences
Using transgenic mouse models and sophisticated electrophysiological analysis, the team meticulously studied the synaptic activity of each IN group during learning and extinction tasks. Thier findings revealed distinct roles for each type. Somatostatin INs were found to mediate feedback inhibition and exhibit plasticity changes during both learning and extinction. Conversely, VIP INs mediate feedforward disinhibition and respond to significant sensory cues.
“The somatostatin and the VIP INs really showed the most distinct differences in the way that they were connected to these principal neurons in the amygdala and in their responses during the acquisition of the associative learning task,” explained the study’s lead author.The PV group, however, demonstrated activity patterns similar to both somatostatin and VIP INs, participating in both feedback and feedforward inhibition.
The researchers emphasized the importance of studying all three types simultaneously.”The only way this was really able to be appreciated was to do a systematic analysis of all three types in all the experiments that we did,because previous studies that had looked at these genetically identified neurons had mostly looked at one group at a time.”
Freezing Behavior and Neuronal Activity
Further investigation revealed a compelling correlation between neuronal activity and behavior. When mice exhibited “freezing” behavior – a common indicator of fear – the activity of somatostatin INs decreased. Conversely, as the mice ceased displaying this fear response, somatostatin IN activity increased. This suggests a direct link between the activity of these neurons and the expression of fear.
These findings have significant implications for enhancing the effectiveness of exposure therapy for PTSD patients. By targeting GABAergic INs, clinicians might potentially be able to amplify the benefits of this established treatment.
Looking ahead, the research team plans to manipulate the activity of each IN group individually to pinpoint which are most critical in driving fear states. They also intend to investigate other recently discovered groups of GABAergic INs within the amygdala. “As we start to understand how these different cell types are involved in regulating these fear behaviors as well as the learning process, it might give us an ultimate prospect to then go in and figure out how might some treatment selectively activate those neurons, for example, to alleviate the fear state,” the lead researcher noted.
Rita Báldi, PhD, a research associate in the Patel laboratory, served as the first author of the study.
This work was supported by National Institutes of Health grant MH11786 and a NARSAD Young Investigator Award.
